288 related articles for article (PubMed ID: 23881541)
41. Mesoporous silica nanoparticles with redox-responsive surface linkers for charge-reversible loading and release of short oligonucleotides.
Zhang J; Niemelä M; Westermarck J; Rosenholm JM
Dalton Trans; 2014 Mar; 43(10):4115-26. PubMed ID: 24457531
[TBL] [Abstract][Full Text] [Related]
42. Chemically reducible lipid bilayer coated mesoporous silica nanoparticles demonstrating controlled release and HeLa and normal mouse liver cell biocompatibility and cellular internalization.
Roggers RA; Lin VS; Trewyn BG
Mol Pharm; 2012 Sep; 9(9):2770-7. PubMed ID: 22738645
[TBL] [Abstract][Full Text] [Related]
43. Synthesis of functional core, star polymers via RAFT polymerization for drug delivery applications.
Liu J; Duong H; Whittaker MR; Davis TP; Boyer C
Macromol Rapid Commun; 2012 May; 33(9):760-6. PubMed ID: 22495770
[TBL] [Abstract][Full Text] [Related]
44. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K
Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090
[TBL] [Abstract][Full Text] [Related]
45. A multifunctional nanocarrier based on nanogated mesoporous silica for enhanced tumor-specific uptake and intracellular delivery.
Gao Y; Yang C; Liu X; Ma R; Kong D; Shi L
Macromol Biosci; 2012 Feb; 12(2):251-9. PubMed ID: 22076739
[TBL] [Abstract][Full Text] [Related]
46. Poly(propylene imine) dendrimer caps on mesoporous silica nanoparticles for redox-responsive release: smaller is better.
Nadrah P; Porta F; Planinšek O; Kros A; Gaberšček M
Phys Chem Chem Phys; 2013 Jul; 15(26):10740-8. PubMed ID: 23689395
[TBL] [Abstract][Full Text] [Related]
47. A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative.
Wang X; Wu G; Lu C; Zhao W; Wang Y; Fan Y; Gao H; Ma J
Eur J Pharm Sci; 2012 Aug; 47(1):256-64. PubMed ID: 22522116
[TBL] [Abstract][Full Text] [Related]
48. An optimized mesoporous silica nanosphere-based carrier system with chemically removable Au nanoparticle caps for redox-stimulated and targeted drug delivery.
Zhang L; Wei F; Al-Ammari A; Sun D
Nanotechnology; 2020 Nov; 31(47):475102. PubMed ID: 32413886
[TBL] [Abstract][Full Text] [Related]
49. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
50. Red-Light-Responsive Supramolecular Valves for Photocontrolled Drug Release from Mesoporous Nanoparticles.
Wang D; Wu S
Langmuir; 2016 Jan; 32(2):632-6. PubMed ID: 26700509
[TBL] [Abstract][Full Text] [Related]
51. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
52. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
53. Gated Mesoporous Silica Nanocarriers for a "Two-Step" Targeted System to Colonic Tissue.
González-Alvarez M; Coll C; Gonzalez-Alvarez I; Giménez C; Aznar E; Martínez-Bisbal MC; Lozoya-Agulló I; Bermejo M; Martínez-Máñez R; Sancenón F
Mol Pharm; 2017 Dec; 14(12):4442-4453. PubMed ID: 29064714
[TBL] [Abstract][Full Text] [Related]
54. Biocompatible zwitterionic sulfobetaine copolymer-coated mesoporous silica nanoparticles for temperature-responsive drug release.
Sun JT; Yu ZQ; Hong CY; Pan CY
Macromol Rapid Commun; 2012 May; 33(9):811-8. PubMed ID: 22488562
[TBL] [Abstract][Full Text] [Related]
55. Multifunctional PEG modified DOX loaded mesoporous silica nanoparticle@CuS nanohybrids as photo-thermal agent and thermal-triggered drug release vehicle for hepatocellular carcinoma treatment.
Wu L; Wu M; Zeng Y; Zhang D; Zheng A; Liu X; Liu J
Nanotechnology; 2015 Jan; 26(2):025102. PubMed ID: 25517859
[TBL] [Abstract][Full Text] [Related]
56. Photo-degradable, protein-polyelectrolyte complex-coated, mesoporous silica nanoparticles for controlled co-release of protein and model drugs.
Wan X; Liu T; Hu J; Liu S
Macromol Rapid Commun; 2013 Feb; 34(4):341-7. PubMed ID: 23225111
[TBL] [Abstract][Full Text] [Related]
57. Self-coated interfacial layer at organic/inorganic phase for temporally controlling dual-drug delivery from electrospun fibers.
Zhao X; Zhao J; Lin ZY; Pan G; Zhu Y; Cheng Y; Cui W
Colloids Surf B Biointerfaces; 2015 Jun; 130():1-9. PubMed ID: 25879640
[TBL] [Abstract][Full Text] [Related]
58. Improved controlled release of protein from expanded-pore mesoporous silica nanoparticles modified with co-functionalized poly(n-isopropylacrylamide) and poly(ethylene glycol) (PNIPAM-PEG).
Yu E; Lo A; Jiang L; Petkus B; Ileri Ercan N; Stroeve P
Colloids Surf B Biointerfaces; 2017 Jan; 149():297-300. PubMed ID: 27776334
[TBL] [Abstract][Full Text] [Related]
59. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
Pan YJ; Chen YY; Wang DR; Wei C; Guo J; Lu DR; Chu CC; Wang CC
Biomaterials; 2012 Sep; 33(27):6570-9. PubMed ID: 22704845
[TBL] [Abstract][Full Text] [Related]
60. Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules.
Bhattacharyya S; Wang H; Ducheyne P
Acta Biomater; 2012 Sep; 8(9):3429-35. PubMed ID: 22688089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
